Overview
- 7 inspections across 7 sites are on record.
- 1 Form 483 observation is attributed to this investigator.
- Most recent recorded activity is 2025-09-18.
At a glance
Inspections
7
Sites
7
Observations
1
Career since
Apr 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Mitsubishi Tanabe Pharma America, Inc. | 18 Sep 2025 | Human Drugs | |
| Florida Pharmaceutical Products, LLC | 20 Feb 2025 | Human Drugs | |
| Teva Pharmaceuticals USA, Inc | 29 Sep 2023 | Human Drugs | On file |
| Navinta LLC | 4 May 2023 | Human Drugs | |
| ALBA Bioscience Limited | 31 Aug 2018 | Biologics |
Sites inspected
Mitsubishi Tanabe Pharma America, Inc.Jersey City, United States1 insp.
Florida Pharmaceutical Products, LLCBoca Raton, United States1 insp.
Teva Pharmaceuticals USA, IncParsippany, United States1 insp.
Navinta LLCEwing, United States1 insp.
ALBA Bioscience LimitedPenicuik, United Kingdom1 insp.
Co-investigators
Investigators who share inspections with this person.
Michael Serrano2 shared
Chantae D Mitchell1 shared
Gene R Gunn1 shared
Mayar M Mussa1 shared
Priscilla M Pastrana1 shared
Meihong Liu1 shared
Pankaj H Amin1 shared
Randa Melhem1 shared
Joan Johnson1 shared
Full investigator report
Get the verbatim findings behind Ashley J Burns' 1 observation
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site